The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas
Cancer (2013) - Comments
pubmed: 22972611  doi: 10.1002/cncr.27801  issn: 1097-0142  issn: 0008-543x 

Vikas Sehdev, Ahmed Katsha, Jeffrey Ecsedy, Alexander Zaika, Abbes Belkhiri, Wael El-Rifai